Back to Trades
Sell4
THERMO FISHER SCIENTIFIC INC.
TMO
Total Value
$10.1M
Net $5.0M sold
Sales
$5.0M
3 transactions
Company Information
- Company Name
- THERMO FISHER SCIENTIFIC INC.
- Ticker Symbol
- TMO
- CIK
- 0000097745
Insider Information
- Name
- CASPER MARC N
- Role
- Chairman & CEO, Director
- Location
- WALTHAM, MA
DirectorOfficer
Filing Details
- Filing Date
- Aug 26, 2025
- Transaction Date
- Aug 22, 2025
- Accession Number
- 0000097745-25-000108
- Form Type
- 4
- Net Trading Amount
- -$5.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 22, 2025 | Common Stock | 10,000 | $253.99 | Exercise | $2.5M |
| Aug 22, 2025 | Common Stock | 5,823 | $500.40 | Sale | $2.9M |
| Aug 22, 2025 | Common Stock | 3,579 | $501.65 | Sale | $1.8M |
| Aug 22, 2025 | Common Stock | 598 | $502.26 | Sale | $300.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 22, 2025 | Derivative | 10,000 | $253.99 | Exercise | $2.5M |
Footnotes
- (F1)The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $500.001 to $500.98, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.05 to $501.99, inclusive.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.02 to $502.37, inclusive.
- (F5)The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
- (F6)The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
- (F7)The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.